K Krisch
Impact in
- Pharmacology top 2%
- Cholinesterase and Neurodegenerative Diseases
- Pharmacogenetics and Drug Metabolism
-
- Computational Drug Discovery Methods
Papers in
-
- Enzyme function and inhibition 17
- Enzyme Catalysis and Immobilization 10
- Pharmacology 23
- Cholinesterase and Neurodegenerative Diseases 23
- Co-authors
- Eberhard Heymann (13 shared papers)Wolfgang Junge (12 shared papers)Allan H. Conney (1 shared paper)Rüdiger Arndt (4 shared papers)Hj. Staudinger (4 shared papers)Ulrich Walter (5 shared papers)N. Neuhold (7 shared papers)Horst P. Büch (1 shared paper)
- Journals
- European Journal of Biochemistry (5 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (3 papers)Biochemical Pharmacology (3 papers)Cancer (2 papers)Diabetes (2 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
K Krisch
103 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 110
- Pharmacology 489
- Pharmacology 195
- Computational Theory and Mathematics 242
- Biochemistry 109
- Molecular Biology 841
Countries citing papers authored by K Krisch
This map shows the geographic impact of K Krisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Krisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Krisch more than expected).
Fields of papers citing papers by K Krisch
This network shows the impact of papers produced by K Krisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Krisch. The network helps show where K Krisch may publish in the future.
Co-authors
The 25 scholars most cited alongside K Krisch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1975 | 123 | |
| 2 | 1967 | 103 | |
| 3 | 1966 | 101 | |
| 4 | 1988 | 92 | |
| 5 | 1961 | 66 | |
| 6 | 1969 | 65 | |
| 7 | 1974 | 48 | |
| 8 | 1973 | 47 | |
| 9 | 1989 | 46 | |
| 10 | [Phosphoric acid-bis-(p-nitro-phenylester), a new inhibitor of microsomal carboxylesterases]. | 1967 | 41 |
| 11 | 1975 | 40 | |
| 12 | 1985 | 40 | |
| 13 | 1967 | 35 | |
| 14 | 1973 | 34 | |
| 15 | Monoclonal antibody HISL-19 as an immunocytochemical probe for neuroendocrine differentiation. Its application in diagnostic pathology. | 1986 | 34 |
| 16 | 1985 | 34 | |
| 17 | Solid and cystic tumour of the pancreas; a hormonal-dependent neoplasm? | 1988 | 33 |
| 18 | 1987 | 32 | |
| 19 | 1985 | 31 | |
| 20 | 1962 | 30 |
About K Krisch
K Krisch is a scholar working on Molecular Biology, Pharmacology, Computational Theory and Mathematics, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 106 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (23 papers), Enzyme function and inhibition (17 papers), Computational Drug Discovery Methods (16 papers), Enzyme Catalysis and Immobilization (10 papers), Neuroendocrine Tumor Research Advances (9 papers), Thyroid Cancer Diagnosis and Treatment (8 papers), Biotin and Related Studies (6 papers) and Pancreatic function and diabetes (6 papers). The work is most often cited by research in Pharmacology (489 citations), Pharmacology (195 citations), Computational Theory and Mathematics (242 citations), Biochemistry (109 citations) and Molecular Biology (841 citations). K Krisch has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Eberhard Heymann, Wolfgang Junge, Allan H. Conney, Rüdiger Arndt, Hj. Staudinger, Ulrich Walter, N. Neuhold, Horst P. Büch, S. Srikanta and W. Buzello. Their work appears in journals such as European Journal of Biochemistry, Clinical Chemistry and Laboratory Medicine (CCLM), Biochemical Pharmacology, Cancer and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.